Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 1.1× sales vs its 1.5× historical median P/S.
Fair value ≈ $2.12 · price $1.49 today
Undervalued · 30% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$CVALF Experienced management. Product differentiation. Turnaound complete. Growth emerging. Just scratching the surface. Has It all, and selling at a tremendous discount to current value. Stock coming off Its lows. Multi-bagger easy.
$CVALF Didnt get dividend at fidelity payment date today thought $0.15 fidelity has been doing that they choose not to post the dividend until the next business day
$CVALF eps going wrong way as they write down inventory.
Mgmt is bullish on future, but that is what mgmt always says.
Need to start right here in last half of calendar yr 2025.
Holding for now.
@Kevn1111 Just want to say thank you for keeping "us" informed with your knowledge. I do gain a lot out of your comments and feedback. We happen to share a few of the same information bases (Geo, MM, and SA); however, I don't have a lot of time to devote to the market, so again, I appreciate your time and feedback. I opened a small position of $CVALF when GEO came out with it, so this would be great news.
$CVALF nice Q4 earnings of .04. Growth still occurring. Floor FV of $3.20. But I think they can do .24 in 2025. At 20x this is $4.80.
Company noted headwinds on collagen, but will flip in H2 2025.
Let’s see what mkt thinks about this one today.
$CVALF Agreed. Just added some more. Nice returns. https://www.businesswire.com/news/home/20250107776006/en/Covalon-Announces-Strong-Fourth-Quarter-and-Year-End-Fiscal-2024-Results
$CVALF Earnings out this AM and they look pretty good. New management has done a great job turning this company around in the last year.
I think this one is undervalued.
